Dear Sir, Unaudied Financial results for the quarter & half year ended on 30-09-2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Crestchem Ltd's board approved unaudited financial results for Q2 FY26 and H1 FY26. For Q2 FY26, revenue from operations stood at Rs. 780.31 lakhs vs Rs. 503.09 lakhs in Q2 FY25, a strong ~55% YoY growth. Total income was Rs. 792.34 lakhs, profit before tax was Rs. 138.14 lakhs, and profit after tax was Rs. 99.70 lakhs. For the half year ended Sept 30, 2025, revenue was Rs. 2,125.62 lakhs with PAT of Rs. 214.63 lakhs and EPS of Rs. 7.15. The company generated healthy operating cash flow of Rs. 531.32 lakhs during H1 FY26. The statutory auditors (Samir M. Shah & Associates) issued an unqualified limited review report with no qualifications or adverse remarks.
Strong double-digit revenue growth and robust operating cash flows signal improving business momentum, which is positive for shareholders. However, the absolute scale of operations remains modest, so the stock impact may be limited.